Clinical Trials · NCT07757087

A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Obesity, Compared to a Low-calorie Diet or Placebo

Phase
Phase 1
Recruitment status
Recruiting
Sponsor
Novo Nordisk A/S
Enrollment
120
Start date
Aug 2026
Locations
2 sites, Denmark, Netherlands
Primary endpoint
Change in sleeping metabolic rate (SMR)
View Amycretin compound reference